M. Lichinitzer

Statistics

Publications

Citations

469

H-Index

Active since

2004

Affiliations

The University of Texas Southwestern Medical Center(Current)

Roche (Switzerland)

M. Lichinitzer is an author at The University of Texas Southwestern Medical Center specializing in medicine, breast cancer pharmacotherapy, and metastatic breast cancer.

Publications per year

2004–2009

Publications

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

Jean‐Jacques Body, Ingo Diel, M. Lichinitzer et al. · British Journal of Cancer · 2004 · 335 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial

Debu Tripathy, M. Lichinitzer, A. F Lazarev et al. · Annals of Oncology · 2004 · 100 citations

Medicine, Oncology, Bone Metabolism +16

A Phase II Trial of Cardioprotection with Cardioxane (ICRF-187) in Patients with Advanced Breast Cancer Receiving 5-Fluorouracil, Doxorubicin and Cyclophosphamide

Krsto Kolarić, Vlasta Bradamante, Jožica Červek et al. · Oncology · 2009 · 34 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3